US Supreme Court won't review antitrust case against Merck over mumps vaccines
MLex Summary: Plaintiffs accusing Merck of unlawfully extending its monopoly over mumps vaccines by making false drug-label claims failed to convince the US Supreme Court to review their case. See attached...To view the full article, register now.
Already a subscriber? Click here to view full article